glp-1 drug side effects Your guide to The GLP-1 Agonists and Obesity:
Description
Thinking about a GLP-1 medication
Shima Hadidchi
Full escalation schedules, unit conversions, weight loss data, and switching protocols.
Purpose of the Review Glucagon-like peptide 1 (GLP-1) receptor agonists (RA) have transformed obesity and type 2 diabetes (T2D) management
However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety
